You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 288 No. 2, July 10, 2002 TABLE OF CONTENTS
  JAMA
  •  Online Features
  The World in Medicine
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Melanoma Susceptibility Gene

Joan Stephenson, PhD

JAMA. 2002;288:155.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A spontaneous mutation in a single gene called BRAF is involved in two thirds of cases of melanoma, according to new findings by an international team of researchers from the United Kingdom, Australia, the United States, Italy, and Hong Kong. The group also found that the same gene is mutated in a smaller proportion of a variety of other human malignancies, including colorectal and ovarian cancers.


Mutations in a single gene called BRAF are involved in two thirds of cases of melanoma. (Photo credit: The Skin Cancer Foundation)

The discovery is the fruit of the first stage of the Cancer Genome Project, a systematic genome-wide search for the genes that, when mutated, cause the normal programs of cell proliferation, differentiation, and death to go awry and cause cancer. In healthy cells, BRAF is part of a pathway that mediates a cell's response to growth signals. When mutated, . . . [Full Text of this Article]







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.